Our mission is to enable farmers to gain novel health insights on their fish through routine non-lethal blood testing.

By harnessing the power of data, we empower fish farmers with the knowledge and insights needed to take preventive measures, ensuring the well-being of their fish and setting the stage for industry growth.

To achieve this, we have gathered an exceptional team of people. Please meet them below.

Management team

Charlie Granfelt

CEO

Charlie brings over 30 years of diverse experience across various sectors to his role as CEO of WellFish Tech, including 13 years in commercial and executive positions at Skretting, a global aquaculture feed supplier.

Professor Brian Quinn

Founder / Executive Advisor

Professor of ecotoxicology at the University of the West of Scotland, with >25 years’ experience in biomarker development. More recently CEO/founder of WellFish Tech since 2021 helping to shape the company into the global leader in fish health and welfare assessment.

Shona Banks

COO

Experienced in start-up, growth and commercial environments within the human healthcare industry for over 15 years, Shona brings leadership skills of delivering novel scientific technology products from research to global commercial delivery at scale.

Mark Braceland

CTSO

Obtained a PhD in Animal Health from The University of Glasgow prior to moving to Canada in 2016 and is a founding member of the QASH initiative. Mark is an internationally recognized expert in Fish Health active in maximizing the sustainability of the aquaculture industry and its socio-economic benefits through disrupting how we evaluate stock health.

Dave Cockerill

UK Director

With more than 25 years experience as both an independent and in-house veterinarian, and holding the role of Fish Health Director at two of Scotland’s leading Salmon Producers, Dave’s leading experience of aligning fish health and welfare to sustainable and profitable farming, aims to objectively characterise fish well-being using tools that allow more informed management choices.

Erik Tveteraas

Group Finance Director

Erik brings 12+ years of Aquaculture, Agtech and Foodtech experience. Formerly CFO of an Alt. Protein start-up, and ex-Head of Nutreco’s CVC fund, he thrives in venture-backed scale-up environments. Erik is a CAIA charter holder and holds an MSc from Uni. Edinburgh

Johnny Mone

Chair / Director

John Allan

Director

Former EVP & CTO of the NASDAQ listed Quotient group; >40 years’ experience in human diagnostics industry; extensive knowledge of the global regulatory & in-vitro diagnostics market.